4f3f
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
{{STRUCTURE_4f3f| PDB=4f3f | SCENE= }} | {{STRUCTURE_4f3f| PDB=4f3f | SCENE= }} | ||
===Crystal Structure of Msln7-64 MORAb-009 FAB complex=== | ===Crystal Structure of Msln7-64 MORAb-009 FAB complex=== | ||
+ | {{ABSTRACT_PUBMED_22787150}} | ||
==Disease== | ==Disease== | ||
Line 12: | Line 13: | ||
==Reference== | ==Reference== | ||
- | <references group="xtra"/><references/> | + | <ref group="xtra">PMID:022787150</ref><references group="xtra"/><references/> |
[[Category: Bacillus coli migula 1895]] | [[Category: Bacillus coli migula 1895]] | ||
[[Category: Human]] | [[Category: Human]] |
Revision as of 07:41, 26 March 2014
Contents |
Crystal Structure of Msln7-64 MORAb-009 FAB complex
Template:ABSTRACT PUBMED 22787150
Disease
[MSLN_HUMAN] Antibodies against MSLN are detected in patients with mesothelioma and ovarian cancer.
Function
[MSLN_HUMAN] Membrane-anchored forms may play a role in cellular adhesion.[1] [2] Megakaryocyte-potentiating factor (MPF) potentiates megakaryocyte colony formation in vitro.[3] [4]
About this Structure
4f3f is a 3 chain structure with sequence from "bacillus_coli"_migula_1895 "bacillus coli" migula 1895 and Human. Full crystallographic information is available from OCA.
Reference
- Ma J, Tang WK, Esser L, Pastan I, Xia D. Recognition of mesothelin by the therapeutic antibody MORAb-009: structural and mechanistic insights. J Biol Chem. 2012 Sep 28;287(40):33123-31. Epub 2012 Jul 11. PMID:22787150 doi:http://dx.doi.org/10.1074/jbc.M112.381756
- ↑ Yamaguchi N, Hattori K, Oh-eda M, Kojima T, Imai N, Ochi N. A novel cytokine exhibiting megakaryocyte potentiating activity from a human pancreatic tumor cell line HPC-Y5. J Biol Chem. 1994 Jan 14;269(2):805-8. PMID:8288629
- ↑ Rump A, Morikawa Y, Tanaka M, Minami S, Umesaki N, Takeuchi M, Miyajima A. Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion. J Biol Chem. 2004 Mar 5;279(10):9190-8. Epub 2003 Dec 15. PMID:14676194 doi:http://dx.doi.org/10.1074/jbc.M312372200
- ↑ Yamaguchi N, Hattori K, Oh-eda M, Kojima T, Imai N, Ochi N. A novel cytokine exhibiting megakaryocyte potentiating activity from a human pancreatic tumor cell line HPC-Y5. J Biol Chem. 1994 Jan 14;269(2):805-8. PMID:8288629
- ↑ Rump A, Morikawa Y, Tanaka M, Minami S, Umesaki N, Takeuchi M, Miyajima A. Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion. J Biol Chem. 2004 Mar 5;279(10):9190-8. Epub 2003 Dec 15. PMID:14676194 doi:http://dx.doi.org/10.1074/jbc.M312372200